Medication for children with attentional disorders

J. Perrin; G. Erenberg; R. La Camera; J. A. Nackashi; J. R. Poncher; V. Randall; E. Ruppert; R. C. Wachtel; P. R. Ziring; P. Arango; D. J. Gaebler-Spira; C. Garner; D. Garro; J. H. Mather; J. G. Hollowell; M. McPherson; H. Gewanter; Jr Berlin; D. G. May

Medication for children with attentional disorders

J. Perrin, G. Erenberg, R. La Camera, J. A. Nackashi, J. R. Poncher, V. Randall, E. Ruppert, R. C. Wachtel, P. R. Ziring, P. Arango, D. J. Gaebler-Spira, C. Garner, D. Garro, J. H. Mather, J. G. Hollowell, M. McPherson, H. Gewanter, Jr Berlin, D. G. May

Physical Medicine and Rehabilitation

Research output: Contribution to journal › Review article › peer-review

34 Scopus citations

Abstract

Increasing numbers of children with attentional difficulties have been treated with medication, especially during the last 25 years, and now adolescents and adults are also being recognized with attentional difficulties. This policy statement provides information on the role and the pharmacology of medications used to treat children with attention deficit disorders. Indications and use of medications are discussed and recommended drugs and dose levels are outlined information on adverse effects and common side effects is presented.

Original language	English (US)
Pages (from-to)	301-303
Number of pages	3
Journal	Pediatrics
Volume	98
Issue number	2
State	Published - Aug 1996

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Cite this

@article{05a956e65af84e639c23dce11fb1a253,

title = "Medication for children with attentional disorders",

abstract = "Increasing numbers of children with attentional difficulties have been treated with medication, especially during the last 25 years, and now adolescents and adults are also being recognized with attentional difficulties. This policy statement provides information on the role and the pharmacology of medications used to treat children with attention deficit disorders. Indications and use of medications are discussed and recommended drugs and dose levels are outlined information on adverse effects and common side effects is presented.",

author = "J. Perrin and G. Erenberg and {La Camera}, R. and Nackashi, {J. A.} and Poncher, {J. R.} and V. Randall and E. Ruppert and Wachtel, {R. C.} and Ziring, {P. R.} and P. Arango and Gaebler-Spira, {D. J.} and C. Garner and D. Garro and Mather, {J. H.} and Hollowell, {J. G.} and M. McPherson and H. Gewanter and Jr Berlin and May, {D. G.}",

year = "1996",

month = aug,

language = "English (US)",

volume = "98",

pages = "301--303",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "2",

}

TY - JOUR

T1 - Medication for children with attentional disorders

AU - Perrin, J.

AU - Erenberg, G.

AU - La Camera, R.

AU - Nackashi, J. A.

AU - Poncher, J. R.

AU - Randall, V.

AU - Ruppert, E.

AU - Wachtel, R. C.

AU - Ziring, P. R.

AU - Arango, P.

AU - Gaebler-Spira, D. J.

AU - Garner, C.

AU - Garro, D.

AU - Mather, J. H.

AU - Hollowell, J. G.

AU - McPherson, M.

AU - Gewanter, H.

AU - Berlin, Jr

AU - May, D. G.

PY - 1996/8

Y1 - 1996/8

N2 - Increasing numbers of children with attentional difficulties have been treated with medication, especially during the last 25 years, and now adolescents and adults are also being recognized with attentional difficulties. This policy statement provides information on the role and the pharmacology of medications used to treat children with attention deficit disorders. Indications and use of medications are discussed and recommended drugs and dose levels are outlined information on adverse effects and common side effects is presented.

AB - Increasing numbers of children with attentional difficulties have been treated with medication, especially during the last 25 years, and now adolescents and adults are also being recognized with attentional difficulties. This policy statement provides information on the role and the pharmacology of medications used to treat children with attention deficit disorders. Indications and use of medications are discussed and recommended drugs and dose levels are outlined information on adverse effects and common side effects is presented.

UR - http://www.scopus.com/inward/record.url?scp=9344223922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9344223922&partnerID=8YFLogxK

M3 - Review article

C2 - 8692637

AN - SCOPUS:9344223922

SN - 0031-4005

VL - 98

SP - 301

EP - 303

JO - Pediatrics

JF - Pediatrics

IS - 2

ER -

Medication for children with attentional disorders

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this